Mylan Laboratories Limited (Sterile Products Division) recalls Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC
Mylan recalls Rifampin injections for possible reduced effectiveness due to discoloration from impurities. Affected lots manufactured in 2019-2020.
Lower-risk recall
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.
Contact the company & request your remedy
What happened, in plain English
Mylan is recalling Rifampin injections that may have discoloration from impurities, which could make the medicine less effective. This affects patients using the medication as prescribed by their doctor. Read more at govinfonow.com/recall/37869-mylan-rifampin-injection-recall-possible-reduced-effectiveness-due-to-discoloration.
Source Summary by GovInfoNow · govinfonow.com/recall/37869-mylan-rifampin-injection-recall-possible-reduced-effectiveness-due-to-discoloration · Updated October 5, 2026 · FDA enforcement record: FDA #D-0139-2020
Cite this page
“Mylan Rifampin Injection Recall: Possible Reduced Effectiveness Due to Discoloration.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37869-mylan-rifampin-injection-recall-possible-reduced-effectiveness-due-to-discoloration. Based on FDA recall #D-0139-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0139-2020%22&limit=1).
Why it’s dangerous
The injections may show discoloration due to impurities that could reduce the medicine's effectiveness. This means the treatment might not work as intended for some patients.
Who’s affected
Patients prescribed Rifampin injections by their doctor. Those using the medication as directed are most at risk.
How to tell if you have this one
Check for discoloration in the vial. The product was manufactured for Mylan Institutional LLC in Rockford, IL with specific lot numbers (7008334, 7008417) and expiration dates (April 2020, October 2020).
- Brand
Mylan- Category
Drug
What to do — step by step
Check for Discoloration
Look for discoloration in the vial before using the medication.
Questions people ask
Is this product safe to use?
The product may have reduced effectiveness due to discoloration, but it is not unsafe to use. Patients should follow their doctor's instructions.
What should I do if I have discoloration?
Check the vial for discoloration. If present, do not use the medication and contact your doctor.
Which lots are affected?
Lots 7008334 (expiring April 2020) and 7008417 (expiring October 2020).
Contact Mylan
We’ve drafted a message you can send Mylan to request your refund or repair — edit it as you like.
Subject: Recall D-0139-2020 — Mylan Mylan Hello, I own a Mylan that is covered by recall D-0139-2020 from Mylan. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0139-2020 (October 7, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0139-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.